USE OF BETA-CATENIN AS A BIOMARKER TO TREAT CANCERS USING AN ANTI-DKK-1 ANTIBODY

MA46673AUndetermined Publication Date: 2019-09-04LEAP THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA46673
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2016-10-26
Filing Date: 2017-10-26
Publication Date: 2019-09-04

Application Information

Patent Timeline

26 Oct 2016

Priority

26 Oct 2017

Application

MA46673

04 Sep 2019

Publication

MA46673A

IPC: A61K39/395

CPC: A61K39/3955; A61K31/337; C07K16/18; C12Q1/6886; A61K2039/505; A61K2039/55; C07K2317/21; C07K2317/76

Inventors: KAGEY Michael H.; SIRARD Cynthia A.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.